Metagenomic Sequencing Market

Illumina (US) and Thermo Fisher Scientific (US) are the Prominent Players in the Metagenomic Sequencing Market

The metagenomic sequencing market is projected to reach USD 2.3 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 17.0%. The growth of this market is driven by factors such as the significant applications of metagenomics in various fields, the various initiatives and funding from government & private bodies for large-scale sequencing projects, and the declining cost of sequencing. The availability of cloud computing for data management is another factor providing market players with growth opportunities.

Following are the prominent players in the metagenomic sequencing market–Illumina, Inc. (US), Thermo Fisher Scientific, Inc (US), QIAGEN N.V. (Netherlands), PerkinElmer (US), Oxford Nanopore Technologies Ltd (UK), BGI Group (China), Macrogen Inc. (South Korea), GENEWIZ (US), Eurofins Scientific (Luxembourg), Novogene Corporation (China), Zymo Research Corporation (US), NuGEN Technologies, Inc (US), IntegraGen SA (France), Microsynth AG (Switzerland), and DNAStar, Inc (US).

An analysis of the market developments between 2016 and 2019 has revealed that strategies, such as acquisitions were adopted by market players to strengthen their product portfolio and maintain a competitive position in the metagenomic sequencing market.

To know about the assumptions considered for the study download the pdf brochure

Illumina (US) dominates the next-generation sequencing market with its technologically advanced innovative platforms and associated sequencing products. The company’s product portfolio includes a wide range of highly interconnected products, including sequencing, genotyping, gene expression, and molecular diagnostic products. Illumina also offers metagenomic sequencing services, which further strengthens its market position. Over the past three years, Illumina has launched several products to maintain its leading position in the metagenomic sequencing market. It also invests a significant amount of its revenue on R&D expenditure in order to sustain continuous product development. In 2018, Illumina invested 18.7% of its revenue on R&D. The company also focuses on strategic agreements with leading players in the market to co-develop advanced technologies and strengthen its research & commercialization capabilities. In the past three years, Illumina has entered into agreements with Lundbeck Foundation GeoGenetics Centre (Denmark), KingMed Diagnostics, Genome.One (Australia), GeneDx (US), and HudsonAlpha (US) to co-develop advanced sequencing technologies to serve its customers efficiently. With its strong product portfolio and wide geographic presence, the company is expected to grow at a high rate in the metagenomic sequencing market during the forecast period.

Thermo Fisher Scientific (US) offers an extensive range of products, including analytical instruments, equipment, reagents & consumables, software & services for research, analysis, discovery, and diagnostics. In addition to a robust portfolio of NGS products (that include metagenomic sequencing products), the company also has a substantial geographic presence. Thermo Fisher Scientific launched a number of products in the past three years, including the Oncomine Childhood Cancer Research Assay and the Oncomine Immune Response Research Assay.

With its strong product portfolio, continuous R&D, and wide geographic reach, Thermo Fisher Scientific is expected to significantly grow during the forecast period in the NGS sample preparation and sequencing market.

Related Reports:

Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 7350
RI Published ON
9/9/2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Metagenomic Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved